Skip to main content
    K

    Kyverna Therapeutics, Inc. Common Stock (KYTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.70
    -0.06 (-1.26%)

    Market Cap: $300.94M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Kyverna Therapeutics, Inc. Common Stock (KYTX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Kyverna Therapeutics, Inc. Common Stock (KYTX) has a latest price of $4.70 on Nov 17, 2026, 65.6% below its 52-week high of $13.67. Its price fell 31.7% over the past 12 months.

    Price Chart

    From Feb 2024 to Oct 2026, its highest month-end close was $27.17 in Feb 2024 and its lowest $1.93 in Mar 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart KYTX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for KYTX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 47.0%, and over 6 months it fell 46.0%.

    PeriodChange
    1 month-19.4%
    3 months-47.0%
    6 months-46.0%
    12 months-31.7%
    12 months, with dividends-31.7%
    Price change over each period. Dividends are not included unless the row says so.

    Price by Year

    YearCloseChange
    2026 through Oct 2026$5.67-39.7%
    2025$9.40+151.3%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 22.7% below its 50-day average of $6.08 and 40.2% below its 200-day average of $7.85.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$4.70
    52-week high$13.67-65.6%
    52-week low$4.50+4.6%
    50-day average$6.08-22.7%
    200-day average$7.85-40.2%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 93.9%.

    MeasureValue
    1-year beta2.25
    Largest fall, 1 year-59.0%
    Largest fall, 3 years-93.9%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About KYTX

    What is KYTX's 1-year price change?

    Kyverna Therapeutics, Inc. Common Stock's price fell 31.7% over the past 12 months. With dividends included, the 12-month total return was -31.7%.

    What is KYTX's 52-week high and low?

    Kyverna Therapeutics, Inc. Common Stock's 52-week high is $13.67 and its 52-week low is $4.50. Its latest price of $4.70 on Nov 17, 2026 is 65.6% below the high.

    What is KYTX's beta?

    Kyverna Therapeutics, Inc. Common Stock's 1-year beta against the S&P 500 is 2.25, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 59.0%.

    Is the KYTX chart free?

    Yes. Advanced Charting for KYTX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.